PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Via Mariano Semmola, 52, 80131, Naples, Italy. l.buonaguro@istitutotumori.na.it.\', \'Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Via Mariano Semmola, 52, 80131, Naples, Italy.\', \'Laboratory of Molecular Biology and Viral Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, 80131, Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12967-020-02355-3
?:hasPublicationType
?:journal
  • Journal of translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32370758
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.565
?:rankingScore_hIndex
  • 81
?:title
  • SARS-CoV-2 RNA polymerase as target for antiviral therapy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32370758>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32370758>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all